cobalt chloride co-60

Small moleculeapproved

Approved

Dec 1, 1971

Cobaltous chloride Co-60 is a gamma emitter used in nuclear medicine in the form of high specific activity sources. Co-60 brachytherapy is used to treat carcinoma of the uterine cervix, the second most common cancer in women and the most common cause of death in cancer patients in the developing countries. Co-60 high dose rate brachytherapy unit is a good choice especially for the centers with a small number of brachytherapy procedures. Co-60 demonstrates cost-favorability in Peru and may similarly in other locations. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1970s

  1. Dec 1, 1971

    Bracco — Earliest FDA Approval

  2. Dec 1, 1971

    Bracco — NDA Secondary Org

  3. Dec 1, 1971

    Bracco — NDA Organization

Indications

Mechanism of action

  • lysineBINDING AGENT

    lysine binding agent

Approval history

  • approvedDec 1, 1971

Chemistry & pharmacology

Loading structure…

SMILES

[60Co++]
Mol. weight
59.933822196 g/mol

Oral

No

Parenteral

No

Topical

No

Sources

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
BraccoFor profitNDA2Dec 1, 1971
BraccoFor profitNDADec 1, 1971